TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial.

Olive S Eckstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.